Latest filing published 05 Jan 2017 for Hemostemix Inc., €128k.
No signal scores available.
All filings by Lyle wunderlich on record concern Hemostemix Inc. We count 6 filings; the first trade dates from 2 September 2016 and the latest from 3 January 2017.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 5 January 2017 came the latest disclosure, a transaction for €128k in Hemostemix Inc. Between a trade and the moment it shows up on SEDI, the median delay is 56 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations